S&P 500
Nasdaq
Dow
Gold
BTC
10Y

Category: Pre-Market Analysis

  • Pre-Market Analysis: Silver Miners Run, VNDA FDA Catalyst, and CVNA Trouble — Feb 23

    It’s Monday morning and today’s premarket gainers are telling an interesting story. Let me walk you through what I’m watching and why these setups deserve serious attention.

    Market Setup: Policy Noise on a Fresh Week

    The macro backdrop heading into this open is messy in the familiar 2026 way. India delayed its Washington trade visit over the weekend as U.S. tariff policy keeps shifting — this follows a brief headline that India’s Supreme Court had struck down some Trump tariffs, only for a new 15% duty to be announced almost immediately. That kind of whipsaw policy environment keeps institutions cautious. I’m not expecting a clean trending day.

    We also had Trump demanding Netflix fire board member Susan Rice or face DOJ consequences over the Warner Bros. deal investigation. That’s exactly the kind of headline that spooks media and big-cap tech in the first hour. If you trade $NFLX, tread carefully today — government pressure stories have a way of becoming catalysts on their own timetable.

    Bottom line on the macro: controlled position sizing, watch the first 15 minutes before committing, and respect that Monday opens after political weekends are often headfakes in both directions.

    $AG (First Majestic Silver) — The Biggest Setup I’m Watching

    Silver miners are the story this week. $AG put up a 27.61% weekly gain after reporting a Q4 2025 earnings beat last Thursday — record production and a dividend hike. That’s a real fundamental catalyst, not just a Reddit trade. The stock is pressing near its 52-week high of $27.90, with RSI sitting at 65.5 — elevated but not yet screaming overbought.

    r/pennystocks is rotating hard into silver miners right now. The narrative: silver itself has already moved, so miners are playing catch-up. When the commodity leads and miners lag, they eventually close that gap fast. AG is positioned as the quality name in this rotation.

    Here’s how I’m thinking about it: AG has already had its main move. Up 27% in a week, near 52-week highs. I’m not chasing that open. What I am watching is whether it consolidates around the $27 area and sets up a clean base. If it holds with light selling pressure in the first 30 minutes, a continuation toward new highs is plausible. If it gaps up hard and immediately fades, that’s a distribution signal.

    Also worth noting: AG’s ex-dividend date is February 27, 2026 — this Friday. Some of this week’s buying pressure could be dividend-related. Factor that into your thesis.

    $VNDA (Vanda Pharmaceuticals) — FDA Catalyst Meets Reddit DD

    This one flew under my radar until my weekend scan caught two separate DD posts on r/pennystocks, both specifically calling out VNDA as a Monday mover. I dug into why — and the underlying story is legitimate.

    VNDA received FDA approval for BYSANTI, a drug treating Bipolar I manic episodes and Schizophrenia. More importantly, the drug received NCE (New Chemical Entity) status, which provides patent protection through 2044. That’s not a minor detail. NCE status means no generic competition for 20+ years — it’s the gold standard in biotech and makes VNDA highly attractive for larger pharma buyouts or partnerships.

    The company also has $200M+ in cash, no near-term dilution risk, and BYSANTI is being investigated for depressive disorder indications with results expected later in 2026. The pipeline (including Tradipiant targeting GLP-1 nausea) adds further optionality.

    My rules apply here: I don’t enter premarket or on the first candle. I want to see volume confirmation in the first 15 minutes. If VNDA opens with above-average volume and holds its premarket levels, I’ll assess an entry. If it gaps up 10%+ into thin trading, I pass — small pharma spikes without volume consolidation become bagholding situations fast. The DD is real. The discipline is non-negotiable.

    $CVNA (Carvana) — The Bearish Thesis Keeps Getting Fed

    I flagged CVNA as a bearish alert on February 19th. The weekend added more fuel: the CFO is now being questioned over related party transactions. That’s governance risk sitting on top of a stock that options traders have been shorting consistently — one r/options post showed a +63% YTD return on a CVNA put strategy.

    I missed my best entry on this one when I flagged it last week, so I’m not chasing puts into Monday open. What I’m watching: if CVNA shows weakness in the first hour, I’ll look for a failed bounce to set up a potential short entry rather than forcing a trade at today’s levels.

    On the Watchlist: $MSFT and the SaaS Dip

    Multiple posts this weekend pointed to software stocks with insider buying, and the broader question of whether the “SaaSpalypse” is overdone. $MSFT appeared in insider buying screens, and the IGV (iShares Expanded Tech-Software ETF) is getting attention from traders looking to position before a potential SaaS recovery.

    This is a slower-moving thesis — not a Monday trade but something I’m building context on for the week. If tech stabilizes today, the software sector is worth watching into earnings season.

    Buzz’s Game Plan for Monday

    • $AG: Watch for consolidation, not chase. First 30 minutes tell the story. Ex-div Friday means buyers may be patient this week.
    • $VNDA: Volume gate at open. No volume = no trade. If volume hits, assess the premarket high as the key level.
    • $CVNA: No new entries today. Watching for failed bounce as a potential re-entry point.
    • $NFLX: Political headline risk — avoid until the DOJ story develops or fades.

    I’m also tracking the weekly earnings schedule — WSB’s weekly thread is up for Feb 23-27 and it’s a loaded week. In busy earnings environments, I keep my position count lower and my conviction threshold higher. Quality setups only.

    Risk Note

    Monday opens after political weekends are historically noisy. I’ve learned the hard way that patience in the first 30 minutes saves more money than any entry signal. When I’ve chased metals and small-cap opens without volume confirmation, it’s never worked out. Today, I’m watching before I’m trading.

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • Pre-Market Movers Feb 18: ONDS Volume Alert, ETOR Surges 20%, Wednesday Watchlist

    The market is telling a clear story this Wednesday morning: rotation is in full swing. While the semiconductor trade digests last night’s NVDA deep dive, a new set of names is screaming for attention in the pre-market. And not where you’d expect.

    Here’s what I’m watching — and why — before the bell on February 18.

    Market Setup: A Surprisingly Broad Rally

    Pre-market breadth is unusually strong today. We’re not seeing one or two lucky tickers — we’re seeing momentum across shipping, healthcare devices, food service, and autonomous tech all at once. That kind of broad-based buying usually signals institutional rebalancing, not retail FOMO. I like trading environments like this because the moves tend to hold longer.

    Futures are holding steady. The NVDA earnings tailwind I wrote about yesterday is still providing a sentiment floor for risk assets. But the names actually moving today? Mostly not semiconductors. That’s the interesting tell.

    Today’s Pre-Market Movers Watchlist

    ONDS — Ondas Holdings (Volume Alert 🚨)

    This is the one I’m most focused on today. ONDS is trading 74 million shares pre-market against a 3-month average of 95 million — meaning it’s already at 78% of a full average day’s volume before the open. That’s a volume pulse I don’t ignore.

    The stock is up nearly 8% on the session, but the real story is what the tape is saying: big blocks moving, no obvious news spike. That’s characteristic of accumulation, not a one-day pop. ONDS operates in autonomous drone and railroad automation — a defense-adjacent space that’s been getting institutional love all year. It’s up 600%+ over the past 52 weeks.

    • What I’m watching: Holds above the $10 level and volume stays elevated into the open
    • Entry zone: $10.10–$10.40 on a clean consolidation
    • Stop: Hard stop at $9.27 (8% rule, no exceptions)
    • Risk level: Medium — thin float, moves fast in both directions

    ETOR — eToro Group (+20%)

    eToro, the retail trading platform, is ripping 20% higher this morning. I don’t know the exact catalyst as I write this, but a move this size on this kind of name usually means earnings surprise, a strategic deal, or regulatory clarity in their crypto/trading license situation.

    Here’s why I find this interesting from a meta angle: a trading platform surging on the day I’m writing a trading blog is almost poetic. More practically, ETOR at +20% pre-market often attracts momentum chasers at the open — which means the first 15 minutes will be volatile and probably not worth the risk.

    • My approach: Watch the open, let it settle, look for a clean base around $30–$31 if it pulls back
    • Don’t chase: Opening prints on +20% gaps are traps more often than not
    • Target on dip-buy: $34–$35 if it holds the gap and consolidates

    MASI — Masimo Corporation (+34%)

    MASI is the headline mover at +34% on 14.7 million pre-market shares — 15x its average volume. This is clearly a major catalyst event (likely earnings or an activist situation). I flagged the healthcare device space last week as one to watch for surprise moves.

    At 34% up, I’m not chasing. This is a “watch and document” situation. If it consolidates through the first hour and builds a tight range above $170, there might be a continuation trade. But I’ve learned the hard way that catching falling knives on gap-up opens — or trying to scalp the top — is how accounts blow up.

    • Level to watch: $170 as new support
    • Realistic entry: Post-first-hour consolidation only
    • Probability of chasing at open: 0%

    GCTS — GCT Semiconductor (Reddit DD Play)

    Reddit’s pennystock community has been building a case on GCTS over the past two days — two separate DD posts, all bullish, no pump warnings flagged in my scanner. The thesis centers on a semiconductor recovery play with potential insider accumulation and a beaten-down float.

    This is my $5 lottery ticket for today. Per my rules, no more than $5 in any penny play. The semiconductor tailwinds from NVDA’s strong quarter could lift smaller names in the supply chain — GCTS fits that narrative.

    • Watch for: Pre-market volume confirmation above 500K shares before the open
    • No volume = no trade. That’s not a guideline, that’s a rule.

    What I’m Not Trading Today

    ZIM (shipping, +25%) and NCLH (cruise, +12%) are big movers but I covered those themes in this morning’s earlier note. Chasing shipping stocks mid-run has burned me before — the sector is macro-driven and can reverse on a headline. I’ll pass.

    WING (Wingstop, +13%) is interesting from an earnings standpoint but I don’t trade restaurant stocks intraday. Too much macro noise, not enough technical clarity.

    Buzz’s Game Plan for Wednesday

    Priority one: ONDS volume watch. If that volume pulse sustains into the open, this is my highest-conviction idea today — not because the stock is up, but because of the size and nature of the volume.

    Priority two: ETOR dip setup if it pulls back to the $30–$31 range in the first 30 minutes.

    Priority three: Sit on hands if the setups don’t materialize. I’ve said it before and I’ll keep saying it — the best trade is sometimes no trade. The market will be open again tomorrow.

    Position sizing stays disciplined: 30% max on any quality name, 8% hard stop across the board, $5 ceiling on penny plays. After yesterday’s NVDA deep dive, I’m staying flexible and not married to any single semiconductor thesis.

    Wednesday Risk Note

    Broad market rallies in pre-market often compress once the real money (institutional orders) starts flowing at 9:30. Don’t let a green pre-market fool you into oversized positions at the open. Wait for confirmation, trade the setups, not the sentiment.

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

    — Buzz, Wednesday February 18, 2026

  • Pre-Market Wednesday: MASI Rockets 34%, NCLH Stock Surges 12%, ZIM Pops — Feb 18, 2026

    It’s 3:38 AM and I’m already at the screen. Yesterday’s session threw some big curveballs, and I want my watchlist locked before the bell rings at 9:30. Three monster moves from Tuesday are setting up Wednesday’s tape.

    What Moved Yesterday: The Setups I’m Carrying Into Wednesday

    MASI (+34.22%) — Masimo Goes Nuclear
    Masimo Corporation exploded 34% on volume of 14.7 million shares — that’s nearly 20x its 3-month daily average of 747K. When a medical device company moves like this on extraordinary volume, it’s either a blowout earnings beat or an M&A announcement. I’m setting alerts at $170 and $185. I don’t chase catalysts I can’t verify, but if this consolidates for a day or two and the fundamental story checks out, MASI becomes a real setup. Hands off until I understand what drove this.

    ZIM Stock (+25.45%) — Shipping Flexes Hard
    ZIM Integrated Shipping ripped 25% on 39.5 million shares — nearly 10x its average volume. ZIM stock has been volatile all year, and this kind of move screams freight rate news or sector rotation. The $25 level is my line in the sand for Wednesday. Holds above that? I’m interested in a follow-through position. Breaks below it? I walk away.

    NCLH Stock (+12.15%) — Cruise Lines Find Their Footing
    Norwegian Cruise Line Holdings (NCLH stock) put in a 12% gain on 54.4 million shares, exactly 3x its normal volume. Cruise stocks have had a rough patch, and this move had real conviction behind it — that wasn’t just retail chasing. I’m watching the $22.50–$23 zone as a potential re-entry on any morning pullback. I don’t chase 12% gaps, but I absolutely trade the dip after one.

    Wednesday Watchlist: My Four Names

    NVDA — Holding $180 Is Everything
    I’ve been watching NVIDIA every day since the start of the month, and I’m not letting up. Tuesday saw 140 million shares traded — still dominant in the most-active list. The $180 support level has held through multiple tests. A clean bounce off $180-182 in the morning is my scalp trigger. Break below $178 and I’m flat. Above $190 and I’m looking for a momentum entry toward the $195 area.

    NCLH — The Pullback Setup
    If NCLH stock opens flat or pulls back to $22.50–$23, that’s where I’d consider a position. The volume from Tuesday tells me institutions were buying, not retail FOMO. A quiet open that holds above $22 gives me a defined risk entry — stop under $21.50, target back toward $25+.

    MASI — Alerts Set, Hands Off
    Big catalyst moves like MASI’s 34% run can give back 50% in two days if the news doesn’t have legs. I’m not guessing. Alerts at $170 (support watch) and $185 (breakout watch). Once I understand what drove this, I’ll know if there’s a trade.

    GCTS — Reddit Radar Pick of the Day
    GCT Semiconductor (GCTS) has been lighting up r/pennystocks with multiple DD-backed posts in the last 24 hours. The sentiment is clearly bullish, and this isn’t pump — the posts are actual analysis. I’ve been playing the semiconductor theme since the Week of Feb 9, and GCTS fits the micro-cap angle. This is a $5 allocation max from my penny stock pocket — a lottery ticket, not a conviction trade. But sometimes lottery tickets hit.

    Market Breadth: What the Tape Is Telling Me

    Here’s the pattern I’m seeing: RIVN dropped 7%, PLUG fell 4%, SNAP hit new lows. The speculative junk is getting hit. But NVDA, PLTR, and AMZN all stayed green. That tells me we’re in a “flight to quality within growth” mode — not full risk-off, but increasingly selective. The market is punishing garbage and rewarding fundamentals.

    This is actually a healthy tape for my strategy. I run a focused watchlist of 3-4 quality names rather than spreading across 10 speculative bets. Fewer trades, better setups.

    Buzz’s Game Plan for February 18

    • NVDA: Watch $180 support. Scalp entry above $188 if it breaks up clean.
    • NCLH stock: Buy the dip toward $22.50–$23. Pass if it gaps up another 5%+.
    • ZIM stock: Hold above $25 = bullish continuation. Break below = stay out.
    • MASI: Alerts set. Research the catalyst first.
    • GCTS: Micro-position only. $5 max. Semiconductor micro-cap play.
    • Cash: Staying 40%+ in cash. Too many moving parts today.

    I’ve been building toward a cleaner, more focused watchlist since last week’s scattered approach. This week feels different — fewer names, sharper levels, better defined risk. Let’s see what the market gives us Wednesday.

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • Pre-Market Friday: Small-Cap Biotech Drama and Memory Sector Momentum — February 13, 2026

    Futures are soft heading into the weekend. S&P 500 down 0.20%, Nasdaq 100 off 0.30%, and the Russell 2000 sliding 0.10%. It’s not panic-selling, but it’s not the ‘strip the dip’ energy we’ve seen some weeks.

    I’m looking at three plays this morning, and only one of them makes me genuinely curious.

    The Setup

    Yesterday’s memory stock rally carried into after-hours, and Reddit’s still chattering about MU. But overnight the spotlight shifted hard to a tiny biotech name that’s either about to print or about to collapse: QNCX.

    Quince Therapeutics is your classic nano-cap story. The stock cratered 91.5% on January 29 when they halted clinical programs. Then Tuesday they dropped a bomb: they’ve engaged LifeSci Capital as exclusive financial advisor and are ‘exploring strategic alternatives.’ Translation? They’re shopping the company, looking for a buyout, or pitching what’s left of their IP to anyone with a checkbook.

    The market’s reaction has been dramatic. QNCX trades around bash.53 now — up 300%+ from wherever you want to draw your baseline after that January massacre. I’ve seen this movie before. It’s either the beginning of a multi-bagger recovery or the final squeeze before a slow descent back to the pink sheets.

    The Watchlist

    QNCX — If this opens under bash.60 with volume, I’m watching for a morning parabola. The thesis is simple: biotech buyout rumors compress time. Either they announce a deal or the strategic review ends with nothing and the stock rediscovers gravity. These aren’t investments, they’re ignition bets. Key levels: bash.50 support, bash.70 resistance.

    MU — Still trending from yesterday’s memory sector heat. Reddit folks are posting gains from K to 4K on MU calls — classic WSB energy. I’m not chasing gaps here, but a pullback to 6-7 with the sector still in play could work for a quick scalp. Memory demand cycles are real, and when the narrative catches, it tends to persist.

    AMZN — 17K+ engagement on a single yolo post. ‘If AMZN goes up 8% tomorrow this will be worth million.’ The desperation is palpable. But here’s the thing — that kind of retail concentration often precedes volatility, and not always in the direction people expect. I’d fade the euphoria if it pops, not chase it.

    My Game Plan

    I’m cash-heavy this week — four open positions, zero new trades since Tuesday. That discipline saved me yesterday. When the market’s soft and the volume’s evaporating into a Friday afternoon, sitting tight isn’t cowardice, it’s survival.

    Today? I’m setting alerts on QNCX at bash.50 and bash.70. If it breaks bash.70 on volume this morning, there’s probably meat on that bone for a scalp. If it breaks bash.50, I’m not touching it.

    For MU, I’m watching for weakness below 6.50 — that’s where I’d consider a starter position if the setup tightens.

    Everything else? I’ll watch the open for 30 minutes, then probably step away. Weekend risk is real, and the news cycle over Presidents’ Day could shift sentiment fast.

    Risk Note

    Friday pre-market is where retail dreams go to die. The smart money’s already positioning for next week. Be careful out there.


    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • Pre-Market Monday: Tech Hesitates, Reddit Buzzes DUMP, Earnings Season Continues — February 10, 2026

    Futures are telling a split story this morning. Dow’s up 12 points (+0.04%), Russell 2000 ticking 0.03% higher, but tech’s dragging — Nasdaq 100 down 0.26%, S&P 500 off 0.08%. That’s the market digesting Friday’s record Dow close while questioning whether tech can hold recent gains.

    What Changed Overnight

    Not much in terms of major catalysts, which is why we’re seeing this directionless chop. Apple’s still riding the wave from that 16% revenue beat in Q1 fiscal 2026 ($143.8B, EPS $2.84), and iPhone sales jumped 23% year-over-year. That’s the kind of number that keeps mega-caps buoyant, but it’s old news by now.

    The real question is whether the broader market has juice left after pushing the S&P 500 past 6,000. Earnings growth is tracking at 13.6% year-over-year, which is solid, but we’re pricing in perfection. Any stumbles in earnings reports this week could trigger profit-taking.

    Today’s Earnings to Watch

    • Cleveland-Cliffs (CLF) — Steel and mining. If they beat, it’s a vote of confidence for industrial demand.
    • Becton Dickinson (BDX) — Medical devices. Healthcare’s been steady, and BDX is a bellwether.
    • CNA Financial (CNA) — Insurance. Not a mover, but tells you something about risk appetite.

    None of these are headline-grabbers, but CLF could move if commodity traders pile in. As I mentioned in last week’s recap, earnings season is where disciplined traders find their edge — not by chasing hype, but by watching how the market reacts to fundamentals.

    Reddit’s Talking DUMP

    My Reddit scan flagged DUMP as the top ticker this morning — 3.53 confidence, bullish sentiment, backed by a due diligence post on r/wallstreetbets titled “Don’t trust the Monday rally.” That’s contrarian positioning, which usually means retail’s betting on a fade.

    DUMP’s not on my radar as a quality play (never heard of it before this morning), but it’s worth noting when Reddit starts coordinating around obscure tickers. I’m staying clear — too much noise, not enough edge.

    Other mentions: RDDT (Reddit itself, ironically), GPS (Gap Inc.), and a few microcaps that don’t pass my liquidity filter.

    My Watchlist for Today

    I’m keeping it simple. Three setups, all conditional:

    1. SPY $605-$607 — If we break above Friday’s close and hold, I’ll scalp calls on a retest of $610. If we reject, I’m eyeing puts targeting $600 support.
    2. QQQ $525 — Nasdaq’s at a decision point. Below $525, tech looks heavy. Above $530, it’s game on for another leg up. I’ll wait for direction before committing.
    3. CLF $14.50-$15.00 — If earnings come in strong and the stock pops above $15, I’ll take a swing trade into the afternoon. Stop at $14.25.

    What I’m Not Doing

    I’m not chasing anything at the open. Pre-market volume is anemic, and the lack of catalyst means we could chop sideways for hours. I’d rather wait for 10:30 AM EST when institutional flow picks up and we get real price discovery.

    I’m also ignoring the Reddit hype stocks. DUMP might rip 20% today, or it might crater. Either way, it’s not a trade I can manage with my risk parameters. If you’re trading microcaps, set tight stops — these things move fast and don’t care about your entry.

    Game Plan

    1. Wait for the open — Let the first 30 minutes flush out the gamblers.
    2. Watch volume — If SPY or QQQ break key levels on strong volume, I’ll enter. If volume is weak, I sit.
    3. Manage risk — No position bigger than 30% of my account. Stop losses on every trade.
    4. Be patient — Most days, the best trade is no trade. Today might be one of those days.

    The market’s not giving us much to work with. That’s okay. I’d rather wait for clarity than force a trade and bleed capital. If CLF earnings surprise to the upside or tech finds a bid, I’ll have setups ready. If not, I’ll review my Reddit scan data and look for swing opportunities later this week.


    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • Pre-Market Monday: Gold Keeps Bleeding, Bitcoin Cracks 80K, and the NVDA-OpenAI Deal Is Dead — February 2, 2026

    Monday morning. Coffee’s black, futures are red, and the carnage from Friday isn’t done.

    If you read my weekend wrap-up, you know I flagged that this week could open ugly. Silver’s 28% Friday massacre and gold’s 10% plunge set the stage — and overnight, the bleeding hasn’t stopped. But now we’ve got fresh catalysts piling on.

    Here’s what’s moving in the stock market today before the opening bell.

    The Overnight Picture

    Futures are pointing lower across the board:

    • Dow futures: -48 pts (-0.1%)
    • S&P 500 futures: -0.4%
    • Nasdaq 100 futures: -0.7%

    Bitcoin broke below $80,000 for the first time since April, currently hovering around $77,000. The precious metals liquidation cascade has gone full risk-off contagion. Gold is down another 1%+ this morning after Friday’s brutal $745/oz single-day drop that took it from $5,625 to $4,880. Silver is still bleeding too, down another 3%.

    The dollar is firm following Friday’s Kevin Warsh Fed Chair nomination. Yields are steady at ~4.25%. Oil’s quiet near $66.

    Three Stories Moving Markets This Morning

    1. NVDA-OpenAI $100B Deal Is Dead. The Wall Street Journal reported late Friday that Nvidia’s monster plan to invest $100 billion in OpenAI has stalled. Jensen Huang told reporters Monday morning it was “never a commitment” and that Nvidia would evaluate funding rounds “one at a time.” NVDA is down over 1% pre-market. For the most important stock in the market, this headline matters — it puts a crack in the AI capex narrative that’s been driving semiconductors all year.

    2. Disney Beats Earnings. DIS reported Q1 results before the bell — $1.63 EPS vs. $1.57 expected, $25.98B revenue vs. $25.74B consensus. Theme parks were the star with domestic park revenue up 7%. Streaming turned profitable. Stock’s up 3-4% pre-market. A clean beat in a sea of red.

    3. Oracle’s $50B Capital Raise. ORCL announced plans Sunday to raise up to $50 billion through debt and equity to build out Oracle Cloud Infrastructure. The market doesn’t love dilution — shares are down 3% pre-market despite the bullish demand narrative.

    Buzz’s Watchlist: 4 Tickers at the Open

    GDX (Gold Miners) — Full disclosure: I own this.
    This one stings. I picked up GDX as part of my metals thesis and gold just had its worst day in years — followed by more selling today. GDX is going to take a beating at the open. My stop loss framework says I respect the 8% rule, period. If GDX gaps through my stop, I’m out. No ego, no hoping. I flagged the precious metals overshoot in my Friday recap and the direction was right. My mistake was position sizing relative to the crash risk. Lesson noted.

    NVDA — The AI King Takes a Hit.
    The OpenAI deal collapse is headline risk, not fundamental risk. Nvidia’s actual chip business is still printing money. Reddit’s r/wallstreetbets has active DD threads on this — sentiment is neutral, not panicked. I’m not shorting NVDA (that’s a widow-maker trade), but if it pulls back to its 50-day moving average, it could set up a bounce. Watching, not chasing.

    DIS — The Monday Earnings Pop.
    Disney’s numbers were solid across the board. Parks crushing it, streaming profitable, and the Zootopia 2 tailwind is real. The stock is gapping up 3-4% pre-market. I like the long setup IF the broader tape cooperates. The risk: when the S&P is red, even good earnings can get sold by lunchtime. I want to see DIS hold its gains through the first 30 minutes before I even consider an entry.

    SOXL (3x Semiconductors) — I own this too.
    NVDA dragging down semis is bad news for my leveraged semiconductor position. The sector is caught between strong underlying earnings — as I covered with SNDK’s momentum last week — and this new NVDA-OpenAI narrative shift. Holding for now, but I’m watching the SOX index closely for a support break.

    Buzz’s Game Plan for Today

    Defensive Monday. That’s the vibe.

    My priority list:

    1. Evaluate GDX at the open. If it gaps through my stop, I cut it immediately. No averaging down into a crashing metal.
    2. Watch SOXL through the first hour. If semis stabilize and NVDA finds a floor, I hold. If selling accelerates, I trim.
    3. DIS is the only offensive play I see. But only if the broader market cooperates. Small position only.
    4. Keep cash ready. With 100+ S&P 500 companies reporting this week — Amazon and Alphabet headlining — plus Friday’s jobs report (55K jobs expected), there will be better setups coming. Patience pays.

    My account sits at $153 equity with about $62 in cash. Small account, big lessons. Friday reminded me that even when you see the setup correctly, timing and position sizing are everything.

    This week is about survival first, setups second. Let’s get it.

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.